Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ambry Genetics logo — Finding Answers Through Quality Genetic Testing

Ambry Genetics

Finding Answers Through Quality Genetic Testing

Founded 1999 United States Aliso Viejo, United States 977 employees Acquired Total: $600.00M Biotechnology, Health Care

General Information

Company Name Ambry Genetics
Founded Year 1999
Location United States Aliso Viejo, United States +2
Employees 977
Industries Biotechnology, Health Care
Funding Stage Acquired
Social

BounceWatch is an independent company data service, not affiliated with Ambry Genetics. To contact Ambry Genetics, visit ambrygen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Ambry Genetics

Ambry Genetics is a leading company in the clinical genomic diagnostic industry, with a strong focus on quality genetic testing. Founded in 1999, the company's dedication to science and advanced technology is evident through its largest genetic sequencing lab in the world and CAP-accreditation and CLIA-licensing. Ambry Genetics is also part of the Konica Minolta family, providing access to a complete suite of diagnostic technology. The scope of clients includes renowned academic institutions, pharmaceutical companies, and top-tier treatment hospitals. The company's commitment to patients is reflected in its partnerships with non-profit organizations to support both patients and clinicians in finding answers. However, it is important to note that Ambry Genetics has faced challenges with fraudulent employment practices, prompting the need for caution among job seekers. The latest Venture Round investment occurred on 19 October 2017, with INCJ being the investor. This investment further solidifies the company's position in the health care industry and its potential for growth and innovation.

Taxonomy: Genetic Testing, Clinical Genomics, Diagnostic Technology, Precision Medicine, Healthcare Partnerships, Non-profit Collaborations, Scientific Expertise, Patient-Centric, Accredited Laboratory, Job Scams, Recruitment Fraud, Biomedical Research, Healthcare Innovation, Clinical Genetic Counseling

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition •••••• 1 •••• •••• 01 Nov 2024
Acquisition •••••• - 01 Jul 2017

Latest News

View All
Sophia Genetics, AstraZeneca partner to improve oncology trials — Fiercebiotech.com
Sophia Genetics, AstraZeneca partner to improve oncology trials
Fiercebiotech.com Feb 14, 2023
Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company's Next Chapter o... — Biospace.com
Freenome Names Aaron Elliott, Ph.D., as Chief Executive Officer to Lead the Company's Next Chapter of Commercial Growth and Product Innovation
Biospace.com Apr 09, 2025
Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strat... — Fox2now.com
Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review
Fox2now.com Nov 10, 2025
Freenome Appoints Linh H. Le as Chief Financial Officer — Biospace.com
Freenome Appoints Linh H. Le as Chief Financial Officer
Biospace.com Nov 23, 2025

Ambry Genetics Alternatives & Competitors

Ambry Genetics vs
REALM IDx, Inc.
REALM IDx, Inc. United States

Pioneering integrated diagnostics for a new realm of understanding.

16 employees
Ambry Genetics vs
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. United States

We transform lives through genetic discovery.

Post Ipo Debt
3218 employees
Biotechnology, Platforms
Compare Ambry Genetics vs BioMarin Pharmaceutical Inc.
Ambry Genetics vs
Genome Medical
Genome Medical United States

Enabling a world where everyone’s health is informed by genetics

Series C
122 employees
Health Care, Life Sciences
Compare Ambry Genetics vs Genome Medical
Also compare with: Ambry Genetics vs Sarepta Therapeutics Sarepta Therapeutics

FAQ About Ambry Genetics

Finding Answers Through Quality Genetic Testing
Ambry Genetics was founded in 1999.
Ambry Genetics is headquartered in Aliso Viejo, United States.
Ambry Genetics operates in the following industries: Biotechnology, Health Care.
Ambry Genetics has approximately 977 employees.
Ambry Genetics has completed 2 funding rounds, raising a total of $600.00M. The latest funding stage is Acquired.
Top alternatives and competitors to Ambry Genetics include REALM IDx, Inc., BioMarin Pharmaceutical Inc., Genome Medical, Sarepta Therapeutics, Level2. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ambry Genetics and REALM IDx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ambry Genetics, https://bouncewatch.com/company/ambry-genetics, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes